Literature DB >> 22722893

Classification, functions, and clinical relevance of extracellular vesicles.

Edwin van der Pol1, Anita N Böing, Paul Harrison, Augueste Sturk, Rienk Nieuwland.   

Abstract

Both eukaryotic and prokaryotic cells release small, phospholipid-enclosed vesicles into their environment. Why do cells release vesicles? Initial studies showed that eukaryotic vesicles are used to remove obsolete cellular molecules. Although this release of vesicles is beneficial to the cell, the vesicles can also be a danger to their environment, for instance in blood, where vesicles can provide a surface supporting coagulation. Evidence is accumulating that vesicles are cargo containers used by eukaryotic cells to exchange biomolecules as transmembrane receptors and genetic information. Because also bacteria communicate to each other via extracellular vesicles, the intercellular communication via extracellular cargo carriers seems to be conserved throughout evolution, and therefore vesicles are likely to be a highly efficient, robust, and economic manner of exchanging information between cells. Furthermore, vesicles protect cells from accumulation of waste or drugs, they contribute to physiology and pathology, and they have a myriad of potential clinical applications, ranging from biomarkers to anticancer therapy. Because vesicles may pass the blood-brain barrier, they can perhaps even be considered naturally occurring liposomes. Unfortunately, pathways of vesicle release and vesicles themselves are also being used by tumors and infectious diseases to facilitate spreading, and to escape from immune surveillance. In this review, the different types, nomenclature, functions, and clinical relevance of vesicles will be discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722893     DOI: 10.1124/pr.112.005983

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  614 in total

Review 1.  Using exosomes, naturally-equipped nanocarriers, for drug delivery.

Authors:  Elena V Batrakova; Myung Soo Kim
Journal:  J Control Release       Date:  2015-08-01       Impact factor: 9.776

Review 2.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.

Authors:  Alexei Verkhratsky; Michela Matteoli; Vladimir Parpura; Jean-Pierre Mothet; Robert Zorec
Journal:  EMBO J       Date:  2016-01-12       Impact factor: 11.598

3.  Studying extracellular vesicle transfer by a Cre-loxP method.

Authors:  Anoek Zomer; Sander Christiaan Steenbeek; Carrie Maynard; Jacco van Rheenen
Journal:  Nat Protoc       Date:  2015-12-10       Impact factor: 13.491

4.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.

Authors:  Joanna Kowal; Guillaume Arras; Marina Colombo; Mabel Jouve; Jakob Paul Morath; Bjarke Primdal-Bengtson; Florent Dingli; Damarys Loew; Mercedes Tkach; Clotilde Théry
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

5.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

6.  AQP2 in human urine is predominantly localized to exosomes with preserved water channel activities.

Authors:  Yuko Miyazawa; Saki Mikami; Keiko Yamamoto; Masaki Sakai; Tatsuya Saito; Tadashi Yamamoto; Kenichi Ishibashi; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2018-02-02       Impact factor: 2.801

7.  Analysis of the thrombotic and fibrinolytic activities of tumor cell-derived extracellular vesicles.

Authors:  Ludovic Durrieu; Alamelu Bharadwaj; David M Waisman
Journal:  Blood Adv       Date:  2018-05-22

8.  Intracellular origin and ultrastructure of platelet-derived microparticles.

Authors:  A A Ponomareva; T A Nevzorova; E R Mordakhanova; I A Andrianova; L Rauova; R I Litvinov; J W Weisel
Journal:  J Thromb Haemost       Date:  2017-07-15       Impact factor: 5.824

9.  Extracellular Vesicles: Evolving Contributors in Autoimmunity.

Authors:  Stergios Katsiougiannis
Journal:  For Immunopathol Dis Therap       Date:  2015

Review 10.  The role of extracellular vesicles in podocyte autophagy in kidney disease.

Authors:  Baichao Sun; Shubo Zhai; Li Zhang; Guangdong Sun
Journal:  J Cell Commun Signal       Date:  2021-02-22       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.